Skip to content

Biosimilar Entry

Client :

Healthcare Company

Challenge :

Client was about to lose exclusivity of several biological compounds

Our Intervention :

Based on historical data we developed a new segmentation and strategy to identify client we could not retain/clients we will keep no matter what/clients on the take and action to retain them

Furthermore, we identify the time it will take them to convert to prioritize.

Added value :

A new strategy which decrease impacts on sales after biosimilar entry